Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 104-109

  Brooks, Rebecca A ^a,b   Rader, Janet S ^a,b   Dehdashti, Farrokh ^a,b   Mutch, David G ^a,b   Powell, Matthew A ^a,b   Thaker, Premal H ^a,b   Siegel, Barry A ^a,b   Grigsby, Perry W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

Author keywords

Cervix cancer; FDG PET; Radiation; Recurrence

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METABOLISM; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR BIOPSY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REGISTRIES; UTERINE CERVICAL NEOPLASMS;

EID: 57649108540     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.08.028     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
2. Plummer M., and Franceschi S. Strategies for HPV prevention. Virus Res. 89 (2002) 285-293
3. Grigsby P.W. The role of FDG-PET/CT imaging after radiation therapy. Gynecol. Oncol. 107 (2007) S27-S29
4. Ryu S.Y., Kim M.H., Choi S.C., Choi C.W., and Lee K.H. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J. Nucl. Med. 44 (2003) 347-352
5. Bodurka-Bevers D., Morris M., Eifel P., Levenback C., Bevers M., Lucas K., and Wharton T. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol. Oncol. 78 (2000) 187-193
6. Chung H.H., Kim S.K., Kim T.H., Lee S., Kang K.W., Kim J.Y., and Park S.Y. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol. Oncol. 103 (2006) 165-170
7. Havrilesky L.J., Wong T.Z., Secord A.A., Berchuck A., Clarke-Pearson D.L., and Jones E.L. The role of PET scanning in the detection of recurrent cervical cancer. Gynecol. Oncol. 90 (2003) 186-190
8. Unger J.B., Ivy J.J., Connor P., Charrier A., Ramaswamy M.R., Ampil F.L., et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol. Oncol. 94 (2004) 212-216
9. Juweid M.E., and Cheson B.D. Positron-emission tomography and assessment of cancer therapy. N. Engl. J. Med. 354 (2006) 496-507
10. Grigsby P.W., Siegel B.A., and Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J. Clin. Oncol. 19 (2001) 3745-3749
11. Sugawara Y., Eisbruch A., Kosuda S., Recker B.E., Kison P.V., and Wahl R.L. Evaluation of FDG PET in patients with cervical cancer. J. Nucl. Med. 40 (1999) 1125-1131
12. Grigsby P.W., Siegel B.A., Dehdashti F., Rader J., and Zoberi I. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J. Clin. Oncol. 22 (2004) 2167-2171
13. Schwarz J.K., Siegel B.A., Dehdashti F., and Grigsby P.W. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298 (2007) 2289-2295
14. Wright J.D., Dehdashti F., Herzog T.J., Mutch D.G., Huettner P.C., Rader J.S., et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-d-glucose-positron emission tomography. Cancer 104 (2005) 2484-2491
15. Kaplan E.L., and Meier P. Nonparametric statistics from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 901-913
16. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57 (1970) 579-594
17. Singh A.K., Grigsby P.W., Dehdashti F., Herzog T.J., and Siegel B.A. FDG-PET lymph node staging and survival of patients with FIGO stage IIIB cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 489-493
18. Zola P., Fuso L., Mazzola S., Gadducci A., Landoni F., Maggino T., et al. Follow-up strategies in gynecological oncology: searching appropriateness. Int. J. Gynecol. Cancer 17 (2007) 1186-1193
19. Morice P., Deyrolle C., Rey A., Atallah D., Pautier P., Camatte S., et al. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. Ann. Oncol. 15 (2004) 218-223
20. Zola P., Fuso L., Mazzola S., Piovano E., Perotto S., Gadducci A., et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol. Oncol. 107 (2007) S150-S154